David Holland Insider Trading $ALIM ALIMERA SCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Holland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Holland. David Holland is Chief Marketing Officer & SVP in ALIMERA SCIENCES INC ($ALIM) and Chief Operating Officer & SVP in ALIMERA SCIENCES INC ($ALIM) and Sr. VP of Sales & Marketing in ALIMERA SCIENCES INC ($ALIM) and SVP of Sales & Marketing in ALIMERA SCIENCES INC ($ALIM) and SVP of Sales and Marketing in ALIMERA SCIENCES INC ($ALIM).
David Holland in ALIMERA SCIENCES INC
Trading Symbol: ALIMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Holland: Chief Operating Officer & SVP, Chief Marketing Officer & SVP, SVP of Sales and Marketing, SVP of Sales & Marketing, Sr. VP of Sales & Marketing
Holdings: 25,630 shares
Current Value: $29,731
Latest Transaction: May 04 2021
$ALIM Market Capitalization: $75.24M
$ALIM Previous Close: $1.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David Holland in ALIMERA SCIENCES INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 3.56 | 500 | 1,781 | 25,630 | 25.1 K to 25.6 K (+1.99 %) |
Mar 10 2021 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Operating Off ... | Payment of Exercise | F | 7.42 | 1,935 | 14,348 | 25,130 | 27.1 K to 25.1 K (-7.15 %) |
Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Option Exercise | A | 5.01 | 16,875 | 84,544 | 16,875 | |
Jan 11 2021 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.00 | 5,625 | 0 | 27,065 | 21.4 K to 27.1 K (+26.24 %) |
Nov 03 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 3.56 | 500 | 1,781 | 21,440 | 20.9 K to 21.4 K (+2.39 %) |
May 01 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 3.61 | 167 | 603 | 20,940 | 20.8 K to 20.9 K (+0.80 %) |
Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.00 | 5,172 | 0 | 20,773 | 15.6 K to 20.8 K (+33.15 %) |
Mar 19 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.00 | 5,172 | 0 | 20,773 | 15.6 K to 20.8 K (+33.15 %) |
Mar 05 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Payment of Exercise | F | 6.14 | 1,270 | 7,798 | 15,601 | 16.9 K to 15.6 K (-7.53 %) |
Mar 05 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Payment of Exercise | F | 6.85 | 1,270 | 8,700 | 16,871 | 18.1 K to 16.9 K (-7.00 %) |
Jan 14 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Option Exercise | A | 6.75 | 14,000 | 94,500 | 14,000 | |
Jan 02 2020 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 7.58 | 106 | 803 | 18,141 | 18 K to 18.1 K (+0.59 %) |
Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 8.24 | 98 | 808 | 18,035 | 17.9 K to 18 K (+0.55 %) |
Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 8.24 | 98 | 808 | 18,035 | 17.9 K to 18 K (+0.55 %) |
Dec 16 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 8.24 | 98 | 808 | 18,035 | 17.9 K to 18 K (+0.55 %) |
Dec 02 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 5.66 | 142 | 804 | 17,937 | 17.8 K to 17.9 K (+0.80 %) |
Nov 04 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.24 | 2,500 | 602 | 264,379 | 261.9 K to 264.4 K (+0.95 %) |
Nov 04 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.28 | 2,850 | 808 | 261,879 | 259 K to 261.9 K (+1.10 %) |
Oct 16 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.40 | 2,020 | 808 | 259,029 | 257 K to 259 K (+0.79 %) |
Oct 02 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.57 | 1,417 | 808 | 257,009 | 255.6 K to 257 K (+0.55 %) |
Sep 17 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.41 | 1,970 | 808 | 255,592 | 253.6 K to 255.6 K (+0.78 %) |
Jan 31 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Payment of Exercise | F | 0.84 | 9,983 | 8,389 | 146,022 | 156 K to 146 K (-6.40 %) |
Jan 31 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Payment of Exercise | F | 0.82 | 9,983 | 8,220 | 156,005 | 166 K to 156 K (-6.01 %) |
Jan 25 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Option Exercise | A | 0.86 | 170,000 | 146,200 | 170,000 | |
Jan 25 2019 | ALIM | ALIMERA SCIENCES I ... | Holland David | Chief Marketing Off ... | Grant | A | 0.00 | 107,600 | 0 | 247,600 | 140 K to 247.6 K (+76.86 %) |
Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Option Exercise | A | 1.16 | 150,000 | 174,000 | 150,000 | |
Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Grant | A | 0.00 | 56,400 | 0 | 165,988 | 109.6 K to 166 K (+51.47 %) |
Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Sell | S | 1.18 | 12,750 | 15,048 | 109,588 | 122.3 K to 109.6 K (-10.42 %) |
Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Sell | S | 1.22 | 12,750 | 15,504 | 122,338 | 135.1 K to 122.3 K (-9.44 %) |
Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Sell | S | 1.23 | 12,750 | 15,695 | 135,088 | 147.8 K to 135.1 K (-8.62 %) |
Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Sell | S | 1.24 | 12,750 | 15,779 | 147,838 | 160.6 K to 147.8 K (-7.94 %) |
Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Option Exercise | A | 1.18 | 150,000 | 177,000 | 150,000 | |
Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Grant | A | 0.00 | 51,000 | 0 | 160,588 | 109.6 K to 160.6 K (+46.54 %) |
Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Option Exercise | M | 1.33 | 27,971 | 37,201 | 0 | |
Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Payment of Exercise | F | 1.50 | 24,801 | 37,202 | 109,588 | 134.4 K to 109.6 K (-18.45 %) |
Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Buy | M | 1.33 | 27,971 | 37,201 | 134,389 | 106.4 K to 134.4 K (+26.28 %) |
Jan 06 2016 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Option Exercise | A | 2.47 | 125,000 | 308,750 | 125,000 | |
Nov 16 2015 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Grant | A | 2.56 | 2,500 | 6,396 | 106,418 | 103.9 K to 106.4 K (+2.41 %) |
May 04 2015 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Grant | A | 3.79 | 1,793 | 6,797 | 103,877 | 102.1 K to 103.9 K (+1.76 %) |
Dec 18 2013 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales & Mark ... | Option Exercise | A | 2.47 | 40,000 | 98,800 | 40,000 | |
Dec 18 2013 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales & Mark ... | Option Exercise | A | 2.47 | 110,000 | 271,700 | 110,000 | |
May 20 2013 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales & Mark ... | Sell | S | 4.13 | 30,000 | 124,008 | 98,362 | 128.4 K to 98.4 K (-23.37 %) |
Dec 21 2012 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales & Mark ... | Option Exercise | A | 1.66 | 40,000 | 66,400 | 40,000 | |
Dec 21 2012 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales & Mark ... | Option Exercise | A | 1.66 | 110,000 | 182,600 | 110,000 | |
Aug 14 2012 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales & Mark ... | Payment of Exercise | F | 2.28 | 3,630 | 8,276 | 125,585 | 129.2 K to 125.6 K (-2.81 %) |
Jul 20 2012 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales & Mark ... | Grant | A | 0.00 | 11,187 | 0 | 129,215 | 118 K to 129.2 K (+9.48 %) |
Feb 14 2012 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales & Mark ... | Option Exercise | A | 1.65 | 30,000 | 49,500 | 30,000 | |
Feb 14 2012 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales & Mark ... | Option Exercise | A | 1.65 | 75,000 | 123,750 | 75,000 | |
Nov 05 2010 | ALIM | ALIMERA SCIENCES I ... | Holland David | Sr. VP of Sales & M ... | Option Exercise | A | 11.15 | 43,864 | 489,084 | 43,864 |
Page: 1